Skip to main content
. 2021 Jan 20;27(2):1149–1166. doi: 10.1007/s10989-020-10157-w

Table 3.

Antigenicity, allergenicity, solubility, and physicochemical property assesment of the primary sequence of multi-epitope-based vaccine construct

Sl. No Features Assessment
1 Antigenicity

1.2317 (Probable ANTIGEN) by VaxiJen v2.0

0.918291 (Probable ANTIGEN) by ANTIGENPro

2 Allergenicity

Probable non-allergen (AllerTOP v.2.0)

Probable non-allergen (AllergenFP v.1.0)

3 Solubility

0.668

(Soluble)

4 Number of amino acids 632
5 Molecular weight

64,366.48

Dalton

6 Theoretical Isoelectric point (pI) 5.12
7 Total number of atoms 8920
8 Formula C2764H4392N800O957S7
9 Estimated half-life

30 h (mammalian reticulocytes, in vitro)

 > 20 h (yeast, in vivo)

 > 10 h (Escherichia coli, in vivo)

10 Instability index

27.70

(Stable)

11 Aliphatic index 59.45
12 Grand average of hydropathicity (GRAVY) − 0.646

Bold denotes that antigenic score is higher than 0.45 (threshold value)